Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews

Medicine and Dentistry

• Adverse Event 100%
• Gynecological Surgery 100%
• Restylane 66%
• Pelvic Pain 66%
• Odds Ratio 66%
• Quality of Life 50%
• Systematic Review 33%
• Pregnancy Rate 33%
• Carboxymethyl Cellulose 33%
• Noxytiolin 33%
• Macrogol 33%
• Birth Rate 33%
• Hartmann Solution 33%
• Public Health 16%
• Heparin 16%
• Dyspareunia 16%
• Subfertility 16%
• Ectopic Pregnancy 16%
• Dextran 16%
• Gonadorelin Agonist 16%
• Politef 16%
• Second Look Surgery 16%
• Chitosan 16%
• Promethazine 16%
• Bowel Obstruction 16%
• Pelvis Pain Syndrome 16%
• Plasminogen Activator 16%
• Adjuvant 16%
• Icodextrin 16%
• Surgicel 16%
• Pelvis Surgery 16%
• Reteplase 16%
• Comorbidity 16%
• Table Salt 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Hyaluronic Acid 66%
• Pelvic Pain 66%
• Carboxymethylcellulose 33%
• Macrogol 33%
• Noxytiolin 33%
• Hartmann Solution 33%
• Oxidized Regenerated Cellulose 16%
• Heparin 16%
• Ectopic Pregnancy 16%
• Gonadorelin Agonist 16%
• Subfertility 16%
• Adjuvant 16%
• Icodextrin 16%
• Politef 16%
• Dextran 16%
• Chitosan 16%
• Promethazine 16%
• Intestine Obstruction 16%
• Reteplase 16%
• Plasminogen Activator 16%
• Dyspareunia 16%
• Pelvis Pain Syndrome 16%
• Table Salt 16%
• Comorbidity 16%
• Critical Micelle Concentration 16%